Scott Tarriff Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Scott Tarriff.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Scott Tarriff. Scott Tarriff is Director in CLINICAL DATA INC ($NOVI) and Director in Synthetic Biologics, Inc. ($SYN) and Director in ZIOPHARM ONCOLOGY INC ($ZIOP) and CEO in EAGLE PHARMACEUTICALS, INC. ($EGRX) and President and CEO in EAGLE PHARMACEUTICALS, INC. ($EGRX).
Latest Insider Trading Transactions of Scott Tarriff
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, NOVI, EGRX, SYN, ZIOP
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 26 2021 | EGRX | EAGLE PHARMACEUTIC ... | Tarriff Scott | CEO | Payment of Exercise | F | 47.70 | 4,631 | 220,899 | 1,546,323 | 1.6 M to 1.5 M (-0.30 %) |
Jan 27 2020 | EGRX | EAGLE PHARMACEUTIC ... | Tarriff Scott | CEO | Payment of Exercise | F | 57.98 | 7,548 | 437,633 | 1,550,954 | 1.6 M to 1.6 M (-0.48 %) |
Jan 07 2020 | EGRX | EAGLE PHARMACEUTIC ... | Tarriff Scott | CEO | Option Exercise | A | 59.80 | 145,700 | 8,712,132 | 145,700 | |
Jan 07 2020 | EGRX | EAGLE PHARMACEUTIC ... | Tarriff Scott | CEO | Grant | A | 0.00 | 58,300 | 0 | 1,558,502 | 1.5 M to 1.6 M (+3.89 %) |
Jan 03 2020 | ZIOP | ZIOPHARM ONCOLOGY ... | Tarriff Scott | Director | Option Exercise | A | 4.72 | 50,562 | 238,653 | 50,562 | |
Dec 06 2019 | SYN | Synthetic Biologic ... | Tarriff Scott | Director | Option Exercise | A | 0.42 | 250,000 | 104,500 | 250,000 | |
Mar 04 2019 | EGRX | EAGLE PHARMACEUTIC ... | Tarriff Scott | CEO | Sell | S | 51.81 | 12,428 | 643,895 | 1,525,177 | 1.5 M to 1.5 M (-0.81 %) |
Mar 04 2019 | EGRX | EAGLE PHARMACEUTIC ... | Tarriff Scott | CEO | Sell | S | 50.51 | 12,000 | 606,120 | 1,537,605 | 1.5 M to 1.5 M (-0.77 %) |
Feb 04 2019 | EGRX | EAGLE PHARMACEUTIC ... | Tarriff Scott | CEO | Sell | S | 42.30 | 900 | 38,070 | 1,549,605 | 1.6 M to 1.5 M (-0.06 %) |
Feb 04 2019 | EGRX | EAGLE PHARMACEUTIC ... | Tarriff Scott | CEO | Sell | S | 41.52 | 29,185 | 1,211,761 | 1,550,505 | 1.6 M to 1.6 M (-1.85 %) |
Jan 25 2019 | EGRX | EAGLE PHARMACEUTIC ... | Tarriff Scott | CEO | Option Exercise | A | 42.40 | 137,200 | 5,817,280 | 137,200 | |
Jan 25 2019 | EGRX | EAGLE PHARMACEUTIC ... | Tarriff Scott | CEO | Grant | A | 0.00 | 61,300 | 0 | 1,579,690 | 1.5 M to 1.6 M (+4.04 %) |
Jan 04 2019 | EGRX | EAGLE PHARMACEUTIC ... | Tarriff Scott | CEO | Sell | S | 40.57 | 302 | 12,252 | 1,518,390 | 1.5 M to 1.5 M (-0.02 %) |
Jan 04 2019 | EGRX | EAGLE PHARMACEUTIC ... | Tarriff Scott | CEO | Sell | S | 39.70 | 5,670 | 225,099 | 1,518,692 | 1.5 M to 1.5 M (-0.37 %) |
Jan 04 2019 | EGRX | EAGLE PHARMACEUTIC ... | Tarriff Scott | CEO | Sell | S | 39.04 | 10,597 | 413,707 | 1,524,362 | 1.5 M to 1.5 M (-0.69 %) |
Jan 04 2019 | EGRX | EAGLE PHARMACEUTIC ... | Tarriff Scott | CEO | Sell | S | 40.03 | 8,500 | 340,255 | 1,534,959 | 1.5 M to 1.5 M (-0.55 %) |
Jan 04 2019 | EGRX | EAGLE PHARMACEUTIC ... | Tarriff Scott | CEO | Sell | S | 39.30 | 6,500 | 255,450 | 1,543,459 | 1.5 M to 1.5 M (-0.42 %) |
Jan 02 2019 | ZIOP | ZIOPHARM ONCOLOGY ... | Tarriff Scott | Director | Option Exercise | A | 1.87 | 126,700 | 236,929 | 126,700 | |
Dec 07 2018 | SYN | Synthetic Biologic ... | Tarriff Scott | Director | Option Exercise | A | 0.69 | 79,500 | 54,815 | 79,500 | |
Jul 03 2018 | EGRX | EAGLE PHARMACEUTIC ... | Tarriff Scott | CEO | Option Exercise | M | 4.04 | 124,804 | 504,208 | 0 | |
Jul 03 2018 | EGRX | EAGLE PHARMACEUTIC ... | Tarriff Scott | CEO | Buy | M | 4.04 | 124,804 | 504,208 | 1,549,959 | 1.4 M to 1.5 M (+8.76 %) |
Apr 03 2018 | EGRX | EAGLE PHARMACEUTIC ... | Tarriff Scott | CEO | Option Exercise | M | 4.04 | 113,104 | 456,940 | 0 | |
Apr 03 2018 | EGRX | EAGLE PHARMACEUTIC ... | Tarriff Scott | CEO | Payment of Exercise | F | 52.69 | 57,895 | 3,050,488 | 1,425,155 | 1.5 M to 1.4 M (-3.90 %) |
Apr 03 2018 | EGRX | EAGLE PHARMACEUTIC ... | Tarriff Scott | CEO | Buy | M | 4.04 | 113,104 | 456,940 | 1,483,050 | 1.4 M to 1.5 M (+8.26 %) |
Jan 09 2018 | EGRX | EAGLE PHARMACEUTIC ... | Tarriff Scott | CEO | Option Exercise | A | 0.00 | 189,000 | 0 | 189,000 | |
Jan 09 2018 | EGRX | EAGLE PHARMACEUTIC ... | Tarriff Scott | CEO | Option Exercise | A | 59.14 | 157,000 | 9,284,980 | 157,000 | |
Jan 03 2018 | ZIOP | ZIOPHARM ONCOLOGY ... | Tarriff Scott | Director | Option Exercise | A | 4.14 | 25,000 | 103,500 | 25,000 | |
Dec 21 2017 | SYN | Synthetic Biologic ... | Tarriff Scott | Director | Option Exercise | A | 0.52 | 200,000 | 104,000 | 200,000 | |
Jan 06 2017 | EGRX | EAGLE PHARMACEUTIC ... | Tarriff Scott | CEO | Option Exercise | A | 84.92 | 200,900 | 17,060,428 | 200,900 | |
Jan 04 2017 | ZIOP | ZIOPHARM ONCOLOGY ... | Tarriff Scott | Director | Option Exercise | A | 5.35 | 25,000 | 133,750 | 25,000 | |
Dec 02 2016 | SYN | Synthetic Biologic ... | Tarriff Scott | Director | Option Exercise | A | 0.80 | 168,750 | 135,000 | 168,750 | |
Nov 18 2016 | SYN | Synthetic Biologic ... | Tarriff Scott | Director | Option Exercise | A | 1.72 | 300,000 | 516,000 | 300,000 | |
Nov 18 2016 | SYN | Synthetic Biologic ... | Tarriff Scott | Director | Option Exercise | A | 1.43 | 300,000 | 429,000 | 300,000 | |
Nov 18 2016 | SYN | Synthetic Biologic ... | Tarriff Scott | Director | Grant | A | 0.00 | 300,000 | 0 | 300,000 | 0 to 300 K |
Apr 05 2016 | EGRX | EAGLE PHARMACEUTIC ... | Tarriff Scott | President and CEO | Sell | S | 40.63 | 30,765 | 1,249,982 | 1,369,946 | 1.4 M to 1.4 M (-2.20 %) |
Mar 03 2016 | EGRX | EAGLE PHARMACEUTIC ... | Tarriff Scott | President and CEO | Sell | S | 63.52 | 11,978 | 760,843 | 1,400,711 | 1.4 M to 1.4 M (-0.85 %) |
Mar 03 2016 | EGRX | EAGLE PHARMACEUTIC ... | Tarriff Scott | President and CEO | Sell | S | 62.70 | 7,802 | 489,185 | 1,412,689 | 1.4 M to 1.4 M (-0.55 %) |
Feb 02 2016 | EGRX | EAGLE PHARMACEUTIC ... | Tarriff Scott | President and CEO | Sell | S | 71.84 | 1,702 | 122,272 | 1,420,491 | 1.4 M to 1.4 M (-0.12 %) |
Feb 02 2016 | EGRX | EAGLE PHARMACEUTIC ... | Tarriff Scott | President and CEO | Sell | S | 69.95 | 2,431 | 170,048 | 1,422,193 | 1.4 M to 1.4 M (-0.17 %) |
Feb 02 2016 | EGRX | EAGLE PHARMACEUTIC ... | Tarriff Scott | President and CEO | Sell | S | 68.52 | 5,260 | 360,415 | 1,424,624 | 1.4 M to 1.4 M (-0.37 %) |
Feb 02 2016 | EGRX | EAGLE PHARMACEUTIC ... | Tarriff Scott | President and CEO | Sell | S | 67.46 | 3,600 | 242,856 | 1,429,884 | 1.4 M to 1.4 M (-0.25 %) |
Feb 02 2016 | EGRX | EAGLE PHARMACEUTIC ... | Tarriff Scott | President and CEO | Sell | S | 66.03 | 5,367 | 354,383 | 1,433,484 | 1.4 M to 1.4 M (-0.37 %) |
Jan 05 2016 | ZIOP | ZIOPHARM ONCOLOGY ... | Tarriff Scott | Director | Option Exercise | A | 8.31 | 40,000 | 332,400 | 40,000 | |
Jan 05 2016 | EGRX | EAGLE PHARMACEUTIC ... | Tarriff Scott | President and CEO | Option Exercise | A | 86.15 | 180,000 | 15,507,000 | 180,000 | |
Jan 05 2016 | EGRX | EAGLE PHARMACEUTIC ... | Tarriff Scott | President and CEO | Sell | S | 87.02 | 2,773 | 241,306 | 1,438,851 | 1.4 M to 1.4 M (-0.19 %) |
Jan 05 2016 | EGRX | EAGLE PHARMACEUTIC ... | Tarriff Scott | President and CEO | Sell | S | 85.65 | 11,776 | 1,008,614 | 1,441,624 | 1.5 M to 1.4 M (-0.81 %) |
Dec 04 2015 | SYN | Synthetic Biologic ... | Tarriff Scott | Director | Option Exercise | A | 2.76 | 125,000 | 345,000 | 125,000 | |
Dec 02 2015 | EGRX | EAGLE PHARMACEUTIC ... | Tarriff Scott | President and CEO | Sell | S | 91.46 | 1,300 | 118,898 | 1,453,400 | 1.5 M to 1.5 M (-0.09 %) |
Dec 02 2015 | EGRX | EAGLE PHARMACEUTIC ... | Tarriff Scott | President and CEO | Sell | S | 90.99 | 3,700 | 336,663 | 1,454,700 | 1.5 M to 1.5 M (-0.25 %) |
Dec 02 2015 | EGRX | EAGLE PHARMACEUTIC ... | Tarriff Scott | President and CEO | Sell | S | 88.80 | 1,500 | 133,200 | 1,458,400 | 1.5 M to 1.5 M (-0.10 %) |
Dec 02 2015 | EGRX | EAGLE PHARMACEUTIC ... | Tarriff Scott | President and CEO | Sell | S | 87.85 | 4,744 | 416,760 | 1,459,900 | 1.5 M to 1.5 M (-0.32 %) |
Dec 02 2015 | EGRX | EAGLE PHARMACEUTIC ... | Tarriff Scott | President and CEO | Sell | S | 86.92 | 2,806 | 243,898 | 1,464,644 | 1.5 M to 1.5 M (-0.19 %) |
Nov 03 2015 | EGRX | EAGLE PHARMACEUTIC ... | Tarriff Scott | President and CEO | Sell | S | 65.50 | 7,626 | 499,503 | 1,467,450 | 1.5 M to 1.5 M (-0.52 %) |
Nov 03 2015 | EGRX | EAGLE PHARMACEUTIC ... | Tarriff Scott | President and CEO | Sell | S | 64.07 | 11,713 | 750,452 | 1,475,076 | 1.5 M to 1.5 M (-0.79 %) |
Oct 05 2015 | EGRX | EAGLE PHARMACEUTIC ... | Tarriff Scott | President and CEO | Sell | S | 68.50 | 1,065 | 72,953 | 1,486,789 | 1.5 M to 1.5 M (-0.07 %) |
Oct 05 2015 | EGRX | EAGLE PHARMACEUTIC ... | Tarriff Scott | President and CEO | Sell | S | 69.27 | 8,235 | 570,438 | 1,487,854 | 1.5 M to 1.5 M (-0.55 %) |
Oct 05 2015 | EGRX | EAGLE PHARMACEUTIC ... | Tarriff Scott | President and CEO | Sell | S | 70.28 | 7,027 | 493,858 | 1,496,089 | 1.5 M to 1.5 M (-0.47 %) |
Oct 05 2015 | EGRX | EAGLE PHARMACEUTIC ... | Tarriff Scott | President and CEO | Sell | S | 72.67 | 1,548 | 112,493 | 1,503,116 | 1.5 M to 1.5 M (-0.10 %) |
Oct 05 2015 | EGRX | EAGLE PHARMACEUTIC ... | Tarriff Scott | President and CEO | Sell | S | 74.36 | 3 | 223 | 1,504,664 | 1.5 M to 1.5 M (0.00 %) |
Sep 29 2015 | ZIOP | ZIOPHARM ONCOLOGY ... | Tarriff Scott | Director | Grant | A | 0.00 | 4,186 | 0 | 4,186 | 0 to 4.2 K |
Sep 03 2015 | EGRX | EAGLE PHARMACEUTIC ... | Tarriff Scott | President and CEO | Sell | S | 75.12 | 49 | 3,681 | 1,504,667 | 1.5 M to 1.5 M (0.00 %) |
Sep 03 2015 | EGRX | EAGLE PHARMACEUTIC ... | Tarriff Scott | President and CEO | Sell | S | 76.09 | 1,878 | 142,897 | 1,504,716 | 1.5 M to 1.5 M (-0.12 %) |
Sep 03 2015 | EGRX | EAGLE PHARMACEUTIC ... | Tarriff Scott | President and CEO | Sell | S | 76.88 | 11,792 | 906,569 | 1,506,594 | 1.5 M to 1.5 M (-0.78 %) |
Sep 03 2015 | EGRX | EAGLE PHARMACEUTIC ... | Tarriff Scott | President and CEO | Sell | S | 77.93 | 2,526 | 196,851 | 1,518,386 | 1.5 M to 1.5 M (-0.17 %) |
Aug 04 2015 | EGRX | EAGLE PHARMACEUTIC ... | Tarriff Scott | President and CEO | Sell | S | 95.39 | 2,342 | 223,403 | 1,520,912 | 1.5 M to 1.5 M (-0.15 %) |
Aug 04 2015 | EGRX | EAGLE PHARMACEUTIC ... | Tarriff Scott | President and CEO | Sell | S | 96.36 | 10,658 | 1,027,005 | 1,523,254 | 1.5 M to 1.5 M (-0.69 %) |
Jul 02 2015 | EGRX | EAGLE PHARMACEUTIC ... | Tarriff Scott | President and CEO | Sell | S | 77.58 | 3,710 | 287,822 | 1,533,912 | 1.5 M to 1.5 M (-0.24 %) |
Jul 02 2015 | EGRX | EAGLE PHARMACEUTIC ... | Tarriff Scott | President and CEO | Sell | S | 78.98 | 6,015 | 475,065 | 1,537,622 | 1.5 M to 1.5 M (-0.39 %) |
Jul 02 2015 | EGRX | EAGLE PHARMACEUTIC ... | Tarriff Scott | President and CEO | Sell | S | 80.28 | 1,483 | 119,055 | 1,543,637 | 1.5 M to 1.5 M (-0.10 %) |
Jul 02 2015 | EGRX | EAGLE PHARMACEUTIC ... | Tarriff Scott | President and CEO | Sell | S | 81.50 | 4,502 | 366,913 | 1,545,120 | 1.5 M to 1.5 M (-0.29 %) |
Jul 02 2015 | EGRX | EAGLE PHARMACEUTIC ... | Tarriff Scott | President and CEO | Sell | S | 42.00 | 120,000 | 5,040,000 | 1,549,622 | 1.7 M to 1.5 M (-7.19 %) |
Mar 17 2015 | EGRX | EAGLE PHARMACEUTIC ... | Tarriff Scott | President and CEO | Option Exercise | A | 46.09 | 125,000 | 5,761,250 | 125,000 | |
Apr 14 2011 | NOVI | CLINICAL DATA INC | Tarriff Scott | Director | Option Exercise | D | 15.60 | 7,500 | 117,000 | 0 | |
Apr 14 2011 | NOVI | CLINICAL DATA INC | Tarriff Scott | Director | Sell | U | 30.00 | 16,600 | 498,000 | 0 | 16.6 K to 0 (-100.00 %) |
Sep 17 2010 | NOVI | CLINICAL DATA INC | Tarriff Scott | Director | Grant | A | 0.00 | 7,600 | 0 | 16,600 | 9 K to 16.6 K (+84.44 %) |
Sep 18 2009 | NOVI | CLINICAL DATA INC | Tarriff Scott | Director | Grant | A | 0.00 | 9,000 | 0 | 9,000 | 0 to 9 K |
Page: 1